Related references
Note: Only part of the references are listed.Epstein-Barr Virus IL-10 Engages IL-10R1 by a Two-step Mechanism Leading to Altered Signaling Properties
Sung Il Yoon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
The EBV Immunoevasins vIL-10 and BNLF2a Protect Newly Infected B Cells from Immune Recognition and Elimination
Simon Jochum et al.
PLOS PATHOGENS (2012)
Syk Activation of Phosphatidylinositol 3-Kinase/Akt Prevents HtrA2-dependent Loss of X-linked Inhibitor of Apoptosis Protein (XIAP) to Promote Survival of Epstein-Barr Virus plus (EBV plus ) B Cell Lymphomas
Olivia Hatton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Epstein-Barr virus LMP2A imposes sensitivity to apoptosis
Michelle Swanson-Mungerson et al.
JOURNAL OF GENERAL VIROLOGY (2010)
The regulation of IL-10 production by immune cells
Margarida Saraiva et al.
NATURE REVIEWS IMMUNOLOGY (2010)
EBV Zta protein induces the expression of interleukin-13, promoting the proliferation of EBV-infected B cells and lymphoblastoid cell lines
Shu-Chun Tsai et al.
BLOOD (2009)
Epstein-Barr virus LMP2A accelerates MYC-induced lymphomagenesis
R. Bultema et al.
ONCOGENE (2009)
Interleukin-21 regulates expression of the immediate-early lytic cycle genes and proteins in Epstein-Barr Virus infected B cells
Danijela Konforte et al.
VIRUS RESEARCH (2009)
Epstein-Barr virus-encoded small RNA induces IL-10 through RIG-I-mediated IRF-3 signaling
M. Samanta et al.
ONCOGENE (2008)
Latent membrane protein 1 of EBV activates phosphatidylinositol 3-kinase to induce production of IL-10
Stacie L. Lambert et al.
JOURNAL OF IMMUNOLOGY (2007)
Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival
Christoph Mancao et al.
BLOOD (2007)
TH1 cells control themselves by producing interleukin-10
Anne O'Garra et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Cholesterol is critical for Epstein-Barr virus latent membrane protein 2A trafficking and protein stability
Masato Ikeda et al.
VIROLOGY (2007)
Analysis of Epstein-Barr virus latent gene expression in endemic Burkitt's lymphoma and nasopharyngeal carcinoma tumour cells by using quantitative real-time PCR assays
Andrew I. Bell et al.
JOURNAL OF GENERAL VIROLOGY (2006)
Epstein-Barr virus LMP2A enhances B-cell responses in vivo and in vitro
Michelle Swanson-Mungerson et al.
JOURNAL OF VIROLOGY (2006)
Transformation of BCR-deficient germinal-center B cells by EBV supports a major role of the virus in the pathogenesis of Hodgkin and posttransplantation lymphomas
D Bechtel et al.
BLOOD (2005)
Latent membrane protein 2A, a viral B cell receptor homologue, induces CD5+ B-1 cell development
A Ikeda et al.
JOURNAL OF IMMUNOLOGY (2004)
Latent membrane protein 2A inhibits transforming growth factor-β1-induced apoptosis through the phosphatidylinositol 3-kinase/Akt pathway
M Fukuda et al.
JOURNAL OF VIROLOGY (2004)
Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo
D Hochberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway
T Portis et al.
ONCOGENE (2004)
Signalling events regulating lymphoid growth and survival
P Brennan
SEMINARS IN CANCER BIOLOGY (2001)
The Epstein-Barr virus latent membrane protein 1 induces interleukin-10 in Burkitt's lymphoma cells but not in Hodgkin's cells involving the p38/SAPK2 pathway
M Vockerodt et al.
VIROLOGY (2001)
The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell
GJ Babcock et al.
IMMUNITY (2000)
Share Paper
